Rapamycin-associated lymphoedema in an infant with Kasabach-Merritt phenomenon

被引：10
作者：
Boccara, O. [1 ,2 ]
Hadj-Rabia, S. [1 ,2 ]
Bourrat, E. [3 ]
Coulombe, J. [1 ,2 ]
Bodemer, C. [1 ,2 ]
机构：
[1] Univ Paris 05, Sorbonne Paris Cite, Dept Dermatol, Inst Imagine,Hop Univ Necker Enfants Malad, 149 Rue Sevres, F-75105 Paris, France
[2] Univ Paris 05, Sorbonne Paris Cite, Reference Ctr Genodermatoses & Rare Skin Dis MAGE, Inst Imagine,Hop Univ Necker Enfants Malad, 149 Rue Sevres, F-75105 Paris, France
[3] Hop Robert Debre, Dept Gen Paediat, F-75019 Paris, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 174卷 / 04期
关键词：
MAMMALIAN TARGET; SIROLIMUS; LYMPHANGIOGENESIS; INHIBITORS;
D O I：
10.1111/bjd.14290
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：933 / 934
页数：2
相关论文
共 10 条
  • [1] Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
    Bissler, John J.
    McCormack, Francis X.
    Young, Lisa R.
    Elwing, Jean M.
    Chuck, Gail
    Leonard, Jennifer M.
    Schmithorst, Vincent J.
    Laor, Tal
    Brody, Alan S.
    Bean, Judy
    Salisbury, Shelia
    Franz, David N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) : 140 - 151
  • [2] Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism
    Desai, N.
    Heenan, S.
    Mortimer, P. S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1322 - 1326
  • [3] Sirolimus for the Treatment of Complicated Vascular Anomalies in Children
    Hammill, Adrienne M.
    Wentzel, MarySue
    Gupta, Anita
    Nelson, Stephen
    Lucky, Anne
    Elluru, Ravi
    Dasgupta, Roshni
    Azizkhan, Richard G.
    Adams, Denise M.
    [J]. PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1018 - 1024
  • [4] Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma
    Kai, Li
    Wang, Zuopeng
    Yao, Wei
    Dong, Kuiran
    Xiao, Xianmin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (03) : 471 - 476
  • [5] Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation
    Karpanen, Terhi
    Wirzenius, Maria
    Makinen, Taija
    Veikkola, Tanja
    Haisma, Hidde J.
    Achen, Marc G.
    Stacker, Steven A.
    Pytowski, Bronislaw
    Yla-Herttuala, Seppo
    Alitalo, Kari
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02) : 708 - 718
  • [6] Sirolimus in pediatric renal transplantation
    Kasap, Belde
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 (07) : 673 - 685
  • [7] How to control lymphangiogenesis: A novel role for rapamycin
    Kerjaschki, D.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (08) : 717 - 719
  • [8] Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis
    Kobayashi, Soichi
    Kishimoto, Takashi
    Kamata, Shigeyuki
    Otsuka, Masayuki
    Miyazaki, Masaru
    Ishikura, Hiroshi
    [J]. CANCER SCIENCE, 2007, 98 (05) : 726 - 733
  • [9] Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
    Teachey, David T.
    Grupp, Stephan A.
    Brown, Valerie I.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (05) : 569 - 580
  • [10] Target of rapamycin inhibitors (Sirolimus and Everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials
    Webster, Angela C.
    Lee, Vincent W. S.
    Chapman, Jeremy R.
    Craig, Jonathan C.
    [J]. TRANSPLANTATION, 2006, 81 (09) : 1234 - 1248
1